Equities
Health CareMedical Equipment and Services
  • Price (USD)199.43
  • Today's Change2.32 / 1.18%
  • Shares traded904.58k
  • 1 Year change-23.43%
  • Beta1.0466
Data delayed at least 15 minutes, as of Jun 29 2022 21:10 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine that help improve patient and hospital outcomes. Its products are sold in approximately 75 countries through Company-owned subsidiaries and branches, as well as, third-party dealers and distributors. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a range of medical specialties. Its business segments include MedSurg and Neurotechnology and Orthopaedics and Spine. Its subsidiaries include Alcott Indemnity Company, Arrinex, Inc., Berchtold Corporation, and BioMimetic Therapeutics, LLC.

  • Revenue in USD (TTM)17.43bn
  • Net income in USD2.02bn
  • Incorporated1946
  • Employees46.00k
  • Location
    Stryker Corp2825 Airview BlvdKALAMAZOO 49002United StatesUSA
  • Phone+1 (269) 389-2600
  • Fax+1 (269) 385-1062
  • Websitehttps://www.stryker.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SYK:NYQ since
announced
Transaction
value
Vocera Communications IncDeal completed06 Jan 202206 Jan 2022Deal completed-26.75%2.97bn
Gauss Surgical IncDeal completed07 Sep 202107 Sep 2021Deal completed-27.91%--
Data delayed at least 15 minutes, as of Jun 29 2022 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Boston Scientific Corporation12.16bn754.00m53.61bn41.00k71.393.2028.934.410.52530.52538.4711.710.38472.436.96296,634.202.563.262.914.0068.5869.406.658.030.77875.910.35730.0019.927.23956.5223.201.75--
Edwards Lifesciences Corp5.36bn1.54bn58.90bn15.70k38.8310.0735.1510.992.442.448.499.410.68531.678.76341,216.6019.6815.9922.1618.9576.5875.1128.7223.632.64--0.09250.0019.2912.0482.5521.428.69--
Becton Dickinson and Co20.03bn1.83bn69.71bn75.00k38.562.8416.993.486.346.3469.3786.030.36523.539.06267,080.003.502.613.932.9645.8146.639.597.491.048.510.431872.7918.2910.16161.0215.4511.394.69
Intuitive Surgical, Inc.5.91bn1.64bn72.51bn9.79k45.025.9936.1012.284.494.4916.1133.720.46842.997.57603,053.2013.1814.1214.3915.6868.8468.8328.1529.384.63--0.000.0031.0116.1060.7218.2245.67--
Stryker Corporation17.43bn2.02bn74.80bn46.00k37.544.9725.184.295.275.2745.5739.780.50091.856.22378,913.005.796.736.587.9562.9164.7511.5613.161.18--0.483842.3919.218.6024.703.901.3911.20
Data as of Jun 29 2022. Currency figures normalised to Stryker Corp's reporting currency: US Dollar USD

Institutional shareholders

37.14%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202227.55m7.29%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 202220.16m5.33%
Greenleaf Asset Management, Inc.as of 31 Mar 202220.06m5.30%
Wellington Management Co. LLPas of 31 Mar 202215.37m4.07%
BlackRock Fund Advisorsas of 31 Mar 202215.31m4.05%
SSgA Funds Management, Inc.as of 31 Mar 202213.82m3.65%
Capital Research & Management Co. (Global Investors)as of 31 Mar 202210.40m2.75%
Fundsmith LLPas of 31 Mar 20227.33m1.94%
Geode Capital Management LLCas of 31 Mar 20225.41m1.43%
Franklin Advisers, Inc.as of 31 Mar 20225.02m1.33%
More ▼
Data from 31 Mar 2022 - 31 Mar 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.